Comparable stake leader
ARMISTICE CAPITAL, LLC
SEC ownership of Evogene Ltd.
Top holders, 13D/G large-stake signals, insider positions, and transaction flow tied to CIK 0001574565.
Disclosed value leader
ARMISTICE CAPITAL, LLC
Comparable rows
0/16
Latest evidence
31 Mar 2026
- Public ticker
- EVGN on Nasdaq
- Parsed ownership sources
- 13F and 3/4/5
- Largest SEC-reported holder
- ARMISTICE CAPITAL, LLC
- Latest parsed ownership date
- 31 Mar 2026
- Issuer CIK
- 0001574565
- Issuer location
- Rehovot, Israel
Ownership snapshot
CIK-linked ownership evidence from parsed SEC filings.
1 signal
Issuer
Names, identifiers, and filing context for this profile.
2 identity fields
Ownership snapshot
Top shareholders of Evogene Ltd. (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Comparable stake leader
ARMISTICE CAPITAL, LLC
Disclosed value leader
ARMISTICE CAPITAL, LLC
Comparable rows
0/16
Latest evidence
31 Mar 2026
13F
3/4/5
Highest disclosed value: $351,572
16 rows are not safely comparable across share classes.
Showing 1-8 of 16 holder rows.
Quick read
ARMISTICE CAPITAL, LLC has the largest disclosed position value at $351.6K.
0 of 16 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.
Open SEC evidence
Opens ARMISTICE CAPITAL, LLC's linked filing trail.
Disclosed position value
Top 5
ARMISTICE CAPITAL, LLC
$351.6K
JANE STREET GROUP, LLC
$14.2K
XTX Topco Ltd
$9.8K
TWO SIGMA SECURITIES, LLC
$9.6K
Daytona Street Capital LLC
$7.7K
Value bars compare disclosed positions; verify each figure against the linked filing evidence.
Detailed SEC evidence table Showing 1-8 of 16 holder rows
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| ARMISTICE CAPITAL, LLC |
13F
Company
|
—
class O/S missing
|
$351,572
456,587 shares
|
— | 31 Mar 2026 |
| JANE STREET GROUP, LLC |
13F
Company
|
—
class O/S missing
|
$14,245
18,500 shares
|
— | 31 Mar 2026 |
| XTX Topco Ltd |
13F
Company
|
—
class O/S missing
|
$9,795
12,721 shares
|
— | 31 Mar 2026 |
| TWO SIGMA SECURITIES, LLC |
13F
Company
|
—
class O/S missing
|
$9,598
12,465 shares
|
— | 31 Mar 2026 |
| Daytona Street Capital LLC |
13F
Company
|
—
class O/S missing
|
$7,703
9,586 shares
|
— | 31 Mar 2026 |
| BNP PARIBAS FINANCIAL MARKETS |
13F
Company
|
—
class O/S missing
|
$7,025
9,124 shares
|
— | 31 Mar 2026 |
| UBS Group AG |
13F
Company
|
—
class O/S missing
|
$4,891
6,352 shares
|
— | 31 Mar 2026 |
| MORGAN STANLEY |
13F
Company
|
—
class O/S missing
|
$2,965
3,851 shares
|
— | 31 Mar 2026 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
Forms 3/4/5 flow
Insider trading overview
Insider buy and sell flow is broadly balanced over the last 12 months. No Buy or Sell transactions have been reported since 13 Jun 2025.
Buys
$0
Insiders: 0
Sells
$0
Insiders: 0
Net
$0
Shares: 0
Window
Last 12 months
4 rolling buckets
Buy value
Sell value
Shares: 0
Shares: 0
| Window (months) | Buy shares | Sell shares | Buy value | Sell value | Net value |
|---|---|---|---|---|---|
| 0-3 | 0 | 0 | $0 | $0 | $0 |
| 3-6 | 0 | 0 | $0 | $0 | $0 |
| 6-9 | 0 | 0 | $0 | $0 | $0 |
| 9-12 | 0 | 0 | $0 | $0 | $0 |
Reporting owners
Insider holders from Forms 3/4/5
Showing 1-10 of 10 reporting-owner rows connected to Evogene Ltd.. Open a relationship link for the CIK-to-CIK filing trail.
Rows
10
Largest Forms 3/4/5 holder
Dan Michael Falk
Net 12M change
$0
Latest report
01 Apr 2026
| Name | Relationship | Holdings Value | Past Year Net Change | Change % | Valuation | Report Date |
|---|---|---|---|---|---|---|
| Dan Michael Falk | Director | Mixed | 18 Mar 2026 | |||
| Adrian John Percy | Director | Mixed | 18 Mar 2026 | |||
| Nir Nimrodi | Director | Mixed | 18 Mar 2026 | |||
| Ofer Haviv | President and CEO, Director | Mixed | 18 Mar 2026 | |||
| Yaron Eldad | Chief Financial Officer | Mixed | 18 Mar 2026 | |||
| Sarit Firon | Director | Mixed | 18 Mar 2026 | |||
| Ilia Zhidkov | Chief Technology Officer | Mixed | 18 Mar 2026 | |||
| Leon Recanati | Director | Mixed | 18 Mar 2026 | |||
| Gabi Tarcic | Chief Development Officer | Mixed | 18 Mar 2026 | |||
| Polina Ravzin | VP Finance | Mixed | 01 Apr 2026 |
Recent insider transactions for Evogene Ltd.
Showing up to 300 recent insider transactions from the last 12 months.
| Insider | Symbol | Class | Transaction | % | SEC-reported value | SEC-reported price | Shares | Shares owned | Date | Ownership |
|---|---|---|---|---|---|---|---|---|---|---|
| Leon Recanati | EVGN | Ordinary shares | 0 | 83,886 | 18 Mar 2026 | Direct | ||||
| Yaron Eldad | EVGN | Ordinary shares | 0 | 4,100 | 18 Mar 2026 | Direct |
* marks a reported price that did not pass the local price check.